2022
DOI: 10.9734/jpri/2022/v34i30b36072
|View full text |Cite
|
Sign up to set email alerts
|

Immunohistochemical Analysis of Expression of Cyclin D1 in Different Grades of Oral Squamous Cell Carcinoma

Abstract: Aims: The present study aimed to evaluate the expression of cyclin D1 in oral squamous cell carcinoma and to find association of expression of cyclin D1 with different histological grades of oral squamous cell carcinoma. Study Design:  It is a cross sectional study. Place and Duration of Study: Oral squamous cell carcinoma samples were collected histopathology laboratory of Ziauddin Hospital, North Nazimabad Karachi. Immunohistochemistry was performed in multiple disciplinary research laboratory of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…The strong brown nuclear staining of epithelial cells was considered positive. Histological sections with good intensity were assessed of cell proliferative cycle causes this increased expression in these areas [16]. The high expression of cyclin D1 drives unchecked cellular proliferation promoting tumor growth; thus, the cyclin D1 carries out a central role in the pathogenesis of cancer and is an oncogenic driver in different types of cancers including breast cancer, lung cancer, and melanoma [10].…”
Section: Resultsmentioning
confidence: 99%
“…The strong brown nuclear staining of epithelial cells was considered positive. Histological sections with good intensity were assessed of cell proliferative cycle causes this increased expression in these areas [16]. The high expression of cyclin D1 drives unchecked cellular proliferation promoting tumor growth; thus, the cyclin D1 carries out a central role in the pathogenesis of cancer and is an oncogenic driver in different types of cancers including breast cancer, lung cancer, and melanoma [10].…”
Section: Resultsmentioning
confidence: 99%